490 related articles for article (PubMed ID: 30543814)
21. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of SDHA inhibited proliferation, migration, and invasion of clear cell renal cell carcinoma cells via inactivation of the Wnt/β-catenin pathway.
Xu X; Zhang N; Gao R; Wang J; Dai Z; Bi J
J Recept Signal Transduct Res; 2022 Apr; 42(2):180-188. PubMed ID: 33602019
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
24. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
[TBL] [Abstract][Full Text] [Related]
25. LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway.
Zhu L; Liu XL; Fu ZQ; Qiu P; Feng T; Yan B; Wei JL
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2313-2320. PubMed ID: 32196582
[TBL] [Abstract][Full Text] [Related]
26. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4.
Liu Y; Jiao D; Tian Z
Mol Med Rep; 2019 Jan; 19(1):711-718. PubMed ID: 30431118
[TBL] [Abstract][Full Text] [Related]
28. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
29. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
[TBL] [Abstract][Full Text] [Related]
30. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis.
Yu DP; Zhou Y
Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025
[TBL] [Abstract][Full Text] [Related]
31. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.
Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C
J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849
[TBL] [Abstract][Full Text] [Related]
33. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
34. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
36. PRMT7 promotes the growth of renal cell carcinoma through modulating the β-catenin/C-MYC axis.
Liu F; Wan L; Zou H; Pan Z; Zhou W; Lu X
Int J Biochem Cell Biol; 2020 Mar; 120():105686. PubMed ID: 31926310
[TBL] [Abstract][Full Text] [Related]
37. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
[TBL] [Abstract][Full Text] [Related]
38. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
[TBL] [Abstract][Full Text] [Related]
39. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.
Lu J; Wei JH; Feng ZH; Chen ZH; Wang YQ; Huang Y; Fang Y; Liang YP; Cen JJ; Pan YH; Liao B; Chen WF; Chen W; Luo JH
Oncotarget; 2017 Mar; 8(13):21461-21471. PubMed ID: 28423523
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]